ACPHS currently has several PGY2 programs in Ambulatory Care settings. Each of these programs are one-year post-graduate training programs that offer the resident a variety of clinical experiences as part of a multi-disciplinary care team, with a focus on ambulatory patient care. The goal is to advance the evidence-based knowledge, skills and abilities of the resident in providing and managing drug therapy for patients and designed to provide residents training experiences to become leaders in pharmacy practice. Each program is a 12-month, full time curriculum to provide the resident with clinical insights and practical experiences in pharmacotherapy. These programs will build upon the training from PharmD education and PGY1 pharmacy residency programs to teach the resident to serve as an expert on the optimal use of medications used in the care of patients with a variety of diseases and optimize the outcomes of patients through provision of evidence-based, patient-centered medication therapy. Each program is described in greater detail below.
Be self-directed, motivated, and display a commitment to professional involvement
Have strong interpersonal and communication skills and a desire to provide patient-centered care to older adults in various practice settings.
Possess a Pharm.D. degree from an ACPE accredited School/College of Pharmacy.
Be eligible for a license to pharmacy in New York State.
Be a U.S. citizen or carry a permanent resident VISA.
Have completed, or expect to complete, a PGY1 ASHP-accredited residency program.
The resident must also complete their licensure within two (2) months of beginning the residency
About Albany College of Pharmacy and Health Sciences
Founded in 1881, Albany College of Pharmacy and Health Sciences (ACPHS) is a private, independent institution with a long tradition of academic and research excellence. The college’s mission is to educate the next generation of leaders to improve the health of our society. ACPHS was named the #1 value-added college in the country by the Wall Street Journal and the Brookings Institution.